161 related articles for article (PubMed ID: 37140212)
1. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W
Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
[TBL] [Abstract][Full Text] [Related]
2. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
3. Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma.
Bertin JB; Buffet C; Leenhardt L; Menegaux F; Chereau N
Langenbecks Arch Surg; 2022 Nov; 407(7):3025-3030. PubMed ID: 35819485
[TBL] [Abstract][Full Text] [Related]
4. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
7. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
9. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
11. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
[TBL] [Abstract][Full Text] [Related]
12. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
13. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
[TBL] [Abstract][Full Text] [Related]
14. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.
Lee YS; Shin SC; Lim YS; Lee JC; Wang SG; Son SM; Kim IJ; Lee BJ
Head Neck; 2014 Jun; 36(6):887-91. PubMed ID: 23733708
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
17. The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.
Weng HY; Yan T; Qiu WW; Fan YB; Yang ZL
J Clin Endocrinol Metab; 2022 May; 107(6):1589-1598. PubMed ID: 35213704
[TBL] [Abstract][Full Text] [Related]
18. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
19. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
[TBL] [Abstract][Full Text] [Related]
20. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]